With mandated social distancing, Steve Rummler Hope Network makes changes in naloxone training

Until a few weeks ago, Sanchez regularly traveled around the state, delivering free overdose-prevention rescue kits assembled by volunteers for the opioid-addiction awareness and activist organization and showing individuals and groups how to administer the lifesaving drug. In mid-March, as the number COVID-19 cases in the state began to climb, SRHN leadership announced that staff would work from home and naloxone trainings would be shifted from in-person to virtual, using platforms like Zoom and FaceTime, audio calls or step-by-step video trainings available on their website.

Continue reading

(Scotland) Supporting people affected by alcohol and drug use

Extra support for people affected by alcohol and drug use during the coronavirus (COVID-19) pandemic has been announced by the Minister for Public Health Joe FitzPatrick, including “a programme to increase access to naloxone in new settings, including investment in kits to add to the existing outlets for naloxone supply”.

Continue reading

Life saving overdose-reversing drug still not being accessed

Despite now being available over the counter, take-home naloxone programs designed to be used by potential overdose witnesses to prevent opioid-related harms, are not being bought in increased numbers, according to the authors of research published online today by the Medical Journal of Australia.

Continue reading

ACMD public evidence gathering: request for written evidence

Forms for members of the public to provide written evidence on young people’s drug use and naloxone provision.

Following advice in response to COVID-19, 3 public evidence gathering days which were being arranged by the ACMD to inform reports on young people’s drug use and naloxone provision have been postponed until further notice. We are instead inviting relevant stakeholders to provide written submissions to help support these workstreams.

Continue reading

A Crucial Conversation

Many of us have had to address the concerns of those who feared that the supply of Take Home Naloxone would increase risk taking behaviours among opiate users, but today we’re able to point to a continually increasing global evidence base that naloxone saves lives. (Links to a PDF of DDN magazine, naloxone article on p16).

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.